COMPOSITIONS FOR REDUCING BODY ODORS AND EXCESS MOISTURE

Abstract: The present invention relates to a perfume-free powder, odor absorbing composition, which is safe for use on skin comprising from about 0.1 % to about 25 %, by weight of the composition, of uncomplexed cyclodextrin; and a powder carrier. The present invention also relates to a powder odor and moisture absorbing composition which additionally comprises from about 5 % to about 60 %, by weight of the composition, of a highly effective moisture absorber. The compositions of the present invention may also contain additional odor controlling agents selected from the group consisting of zeolites, activated charcoal, sodium bicarbonate, antimicrobial agents, and antiperspirants. The present invention also relates to the use of the aforementioned compositions in reducing body odor and excess moisture on occluded skin sites.

Description: COMPOSITIONS FOR REDUCING BODY ODORS AND EXCESS MOISTURE BACKGROUND OF THE INVENTION Body odor is most commonly caused by fatty acids on skin and by malodors from microbial sources. The human skin is naturally populated with numerous micro-organisms which are nourished by various skin secreted substances (eccrine and apocrine sweat, and sebum), skin cell debris, breakdown products of the skin and the organisms themselves. These unpleasant body odors are mainly organic molecules which have different structures and functional groups, such as amines, acids, alcohols, aldehydes, ketones, phenolics, polycyclics, indoles, aromatics, polyaromatics, etc. They can also be made up of sulfur- containing functional groups, such as, thiol, mercaptan, sulf.de and/or disulfide groups. Numerous attempts have been made to control or absorb body odors. Attempts have been made to deprive the microbials responsible for body odor of the moist/humid environment they need to proliferate and grow. Such efforts include the use of powders and/or antiperspirants. Body powders and powder-based compositions of the prior art have limited absorption capabilities. Antiperspirants are not always preferred in a body odor control product since, when used over the entire body, they may interfere with the body's thermal regulatory process by inhibiting perspiration through the action of astringent salts. Additionally, such salts may be irritating to a large number of users, particularly when applying them to sensitive areas such as the pelvic region. Other deodorant compositions aimed at combating controlling odor associated with skin secretions, which have been described in the chemical and cosmetic literature, include emulsion sticks or suspensoid sticks, aerosols, roll-ons, pads, pump sprays, and even soap bars. These known deodorants attempt to control odor through a variety of means. For instance, U.S. Patent No. 5,525,331, to Betts, issued June 11, 1996, discloses compositions which inhibit the growth of micro-organisms in the body-secretions. Deodorants may also include antibacterial compounds which help destroy/control the amount of bacteria present on skin, thereby minimising odor produced via bacterial metabolism of skin secretions. Zeolites are known odor absorbers. However, these solid odor absorbers, in addition to known activated charcoal odor absorbers, lose functionality when wet. Therefore, when wetted by body fluids or when carried in an aqueous solution, these odor absorbers are not preferred as they lose their desired odor absorbent characteristics. Furthermore, zeolites can cause "harsh" feel if too much is deposited onto the skin. In addition to the aforementioned attempts at controlling and/or absorbing body odor, numerous attempts have been made to mask body odors with other odors or perfumes. However, perfumes are often inadequate at fully concealing body odors and may be irritating to the user when used alone for control odor. Thus, there remains a need for an improved odor and moisture absorbing composition, which is essentially free of irritating ingredients such as perfumes or astringent antiperspirants and which is safe and effective for use on the entire body. More particularly, there is a need for a convenient composition which is left on the skin and is capable of absorbing a broad spectrum of body odors and excess moisture that are not fully suppressed by the aforementioned means. It has been discovered that such enhanced body odor and moisture control can be safely provided to the entire body by applying a composition, which is left on the skin, which incorporates odor absorbing, uncomplexed cyclodextrins; highly effective moisture absorbing ingredients; and a powder carrier. It has been discovered that a particular advantage of the present invention is the ability to provide convenient, non-irritating odor and moisture protection when applied to occluded skin areas such as the pelvic region, the external vagina, the panty-area, the bra-line, and skin-folds, which may be very sensitive. Moreover, it has been discovered that the aforementioned benefits may be delivered in a powder carrier which also optionally delivers skin aid benefits to the user such as protection and/or moisturization. These and other objects of the present invention will become readily apparent from the detailed description which follows. All percentages, ratios, and parts herein, in the Specification, Examples, and Claims are by weight unless otherwise stated. The term "g", as used herein, means gram. The term "ml", as used herein, means milliliter. SUMMARY OF THE INVENTION The present invention relates to a perfume-free powder, odor absorbing composition, which is safe for use on skin comprising from about 0.1% to about 25%, by weight of the composition, of uncomplexed cyclodextrin; and a powder carrier. The present invention also relates to a powder odor and moisture absorbing composition which additionally comprises from about 5% to about 60%, by weight of the composition, of a highly effective moisture absorber. The compositions of the present invention may also contain additional odor controlling agents selected from the group consisting of zeolites, activated charcoal, sodium bicarbonate, antimicrobial agents, and antiperspirants. The present invention also relates to the use of the aforementioned compositions in reducing body odor and excess moisture on occluded skin sites. DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a perfume-free, dry powder, odor absorbing, and optionally moisture absorbing composition. The present invention also relates to the use of the aforementioned powder composition in reducing body odor and excess moisture from occluded skin sites wherein the powdered composition is applied to occluded skin. The composition can be applied to occluded skin directly as a spray, shaken from a bottle or canister and applied by hand, or applied via wipe which is dry. The composition of the present invention comprises dry ingredients preferably having particle sizes of from about 1 micron to about 100 microns; more preferred from about 1 micron to about 60 microns; and most preferred from about 1 micron to about 20 microns. As used herein, the particle size refers to the largest dimension of the particle and to the ultimate (or primary) particles. The term "occluded skin", as used herein, refers to regions of a human body covered by undergarments, such as the pelvic area, panty-area, and bra-line; and skin-folds or intertriginous regions, where there is continuing skin to skin contact. The term "body fluids", as used herein, includes eccrine sweat, apocrine sweat, sebum, build up of sensible moisture from transepidermal water loss, vaginal discharge, urine, and mixtures thereof. The term "excess moisture", as used herein, means an undesirable and/or unhealthy level of body fluids deposited on the human skin. The term "body odor" as used herein means odors which are generated as a result of the natural functioning of a human body. Such odors include, but are not limited to odors produced by microorganisms of the human skin (i.e. bacterial decomposition of skin secretions), urine, or vaginal discharge, and mixtures thereof. The term "entire body" means the entire external surface of human or mammalian skin. The term "vaginal odor" relates specifically to those body odors which emanate from the pelvic region of a woman, particularly the vagina and the panty area. A detailed description of essential and optional components of the present invention is given below. CYCLODEXTRIN As used herein, the term "cyclodextrin" includes any of the known cyclodextrins such as unsubstituted cyclodextrins containing from six to twelve glucose units, especially alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and/or their derivatives and/or mixtures thereof. The term "uncomplexed cyclodextrin" as used herein means that the cavities within the cyclodextrin in the composition of the present invention should remain essentially unfilled prior to application to skin in order to allow the cyclodextrin to absorb various odor molecules when the composition is applied to the skin. Preferred cyclodextrins for use in the present invention are alpha-cyclodextrin, beta- cyclodextrin, gamma-cyclodextrin and/or their derivatives. More preferred are beta cyclodextrin, hydroxypropyl alpha-cyclodextrin, hydroxypropyl beta-cyclodextrin, methylated-alpha-cyclodextrin or methylated-beta-cyclodextrin. Most preferred is beta- cyclodextrin. It is also preferable to use a mixture of cyclodextrins. Such mixtures absorb body odors more broadly by complexing with a wider range of odoriferous molecules having a wider range of molecular sizes. The levels of cyclodextrin are from about 0.1% to about 25%, preferably from about 1% to about 20%, more preferably from about 2% to about 15%, most preferably from about 3% to about 10%, by weight of the composition. The complexation between cyclodextrin and odorous molecules occurs rapidly when wetted with body fluids. This is convenient for the user because the cyclodextrins, while on dry skin, will not fill their cavities with other environmental odors which would otherwise render them less efficient for absorbing body odors. More particularly, upon solubilization of the cyclodextrins by the body fluids, the isolated cavities become available to form inclusion complexes with the body odor molecules. Thus, ultimately, the availability of solubilized uncomplexed cyclodextrin is essential for an effective and efficient odor control performance. Cyclodextrins having small particle sizes aid in providing higher cyclodextrin surface availability for odor absorption and therefore are preferred. As used herein, the particle size refers to the largest dimension of the particle and to the ultimate (or primary) particles. Small particle cyclodexrins of this invention are those having a particle size of less than about 12 microns, preferably less than about 10 microns, and more preferably less than about 5 microns. A more complete description of the cyclodextrins, cyclodextrin derivatives, and cyclodextrin particle sizes useful in the present invention can be found in U.S. Patent No. 5,429,628, Trinh et al., issued July 4, 1995, which is incorporated herein by reference in its entirety. POWDER CARRIER The cyclodextrins and other optional components useful in the present invention should be dispersed in a pharmaceutically-acceptable powder carrier for convenient, uniform application and disbursement onto the skin. The term "pharmaceutically-acceptable", as used herein, means a powder suitable for topical use on the skin without undue toxicity, irritation, allergic response, and the like. The powder carrier also helps prevent any solubilized cyclodextrin from washing away from the desired skin contact. Powder carriers useful in the present invention include powders known in the art to be safe for human skin. Such powders include but are not limited to cornstarch (topical starch), talc, rice starch, oat starch, tapioca starch, microcrystalline cellulose (for example Avicel®), aluminum starch octenyl succinate (sold by National Starch & Chemical Co. as Dry Flo® Pure, Dry Flo® XT, and/or Dry Flo® PC), kaolin, and mixtures thereof. Preferred is cornstarch. The powder carrier of the present invention will comprise from about 10% to about 95%, preferably from about 15% to about 80%, more preferably from about 25% to about 50%, by weight of the composition. HIGHLY EFFECTIVE MOISTURE ABSORBERS Highly effective moisture absorbers may optionally be included in the present invention to aid in reducing excess moisture on occluded skin. Highly effective moisture absorbers also increase the flowability (the ability to flow without caking due to moisture) of the compositions of the present invention. As used herein, the phrase "highly effective moisture absorbers" refers to silicas (silicone dioxide), silicates or carbonates wherein the silicates and carbonates are formed by reaction of a carbonate or silicate with the alkali (IA) metals, alkaline earth (IIA) metals, or transition metals. Preferred highly effective moisture absorbers are calcium silicate, amorphous silicas, calcium carbonate, magnesium carbonate, or zinc carbonate, and mixtures thereof. Some specific examples of the silicates and carbonates useful in the present invention are more fully explained in Van Nostrand Reinhold's Encyclopedia of Chemistry. 4th Ed. pages 155, 169, 556, and 849, (1984), which is incorporated herein by reference. Preferred are synthetic versions of the highly effective moisture absorbers, particularly in regards to silicas and silicates due to safety risks related to crystalline silica. Synthetic versions are formed by controlled chemical reactions in a manufacturing process rather than using a natural, mined version of these compounds which is then further refined. Synthetic carbonates useful in the present invention can be obtained from various suppliers such as Mallinckrodt or Whittaker, Clark, and Daniels. Examples of synthetic calcium silicates useful in the present invention are Hubersorb® 250 or Hubersorb® 600 available from J.M. Huber. It is preferred that the highly effective moisture absorbers comprise from about 5% to about 60%; more preferred, from about 10% to about 50%; and most preferred, from about 20% to about 40% by weight of the total compo ADJUNCT ODOR CONTROLLING AGENTS Optionally, the compositions of the present invention may comprise zeolites, carbon odor-controlling agents, sodium bicarbonates, antimicrobial agents and/or antiperspirant ingredients for added body odor control. The term "zeolite", as used herein, refers to non-fibrous zeolites. When included in the present invention, zeolites may be present from about 0.1% to about 25%, preferably from about 1% to about 15%, by weight of the composition. A detailed description of zeolites useful in the present invention is found in U.S. Patent No. 5,429,628, Trinh et al., issued July 4, 1995, incorporated herein by reference in its entirety. Carbon odor-controlling agents described in U.S. Patent No. 5,429,628 may be used in the present invention at a level of from about 0.1% to about 25%, by weight of the composition. Sodium bicarbonate is known in the art for its use as an odor absorber. An example of sodium bicarbonate and its use as an underarm deodorant is found in U.S. Patent No. 4,382,079, to Marschner, issued May 3, 1983, which is incorporated herein in its entirety by reference. When included in the present invention, sodium bicarbonate may be present from about 0.1% to about 50%, by weight of the composition. The antimicrobial agents of the present invention are selected from a group consisting of antibacterial agents, antifungal agents, and mixtures thereof. Antimicrobial agents help destroy and/or control the amount of bacteria and or fungi present on the skin. Preferred antimicrobial agents are zinc phenolsulfonate, zinc oxide, triclosan, Zelec® AM by DuPont, zinc ricinoleate, zinc undecylenate, and mixtures thereof. More preferred are zinc phenolsulfonate, zinc oxide, and triclosan. Triclosan is available from Ciba-Geigy as Irgasan DP-300. Examples of antimicrobial agents useful in the present invention are found in the Cosmetic Bench Reference. 1994 Edition, page 10, which is incorporated herein by reference. When included in the present invention, the antimicrobials are at a level of from about 0.01% to about 25%. Preferably from about 0.1% to about 10%, by weight of the present composition. When used on the underarms, antiperspirant ingredients may be included in the present invention. Examples of antiperspirants known in the art are found in the Cosmetic Bench Reference. 1994 Edition, page 13, which is incorporated herein by reference. When included in the present invention, antiperspirants may be present from about 0.1% to about 25%, by weight of the composition. SKIN AIDS The compositions of the present invention also optionally include skin aids. The term "skin aids", as used herein, refers to skin protectants, emollients, and moisturizers. Skin protectants useful in the present invention are found in the Cosmetic Bench Reference. 1994 Edition, page 53; and the Monograph on Skin Protectant Drug Products for Over-the-Counter Human Use, 21 CFR 347. Preferred skin protectants are corn starch, kaolin, mineral oil, sodium bicarbonate, dimethicone, zinc oxide, colloidal oatmeal, and mixtures thereof. When present, the skin protectants comprise from about 0.1% to about 80%, preferably from about 0.1% to about 30%, most preferably from about 0.1% to about 10%, by weight of the composition. Emollients and moisturizers useful in the present invention can be found in the Cosmetic Bench Reference. 1994 Edition, pages 27-32 and 46-48, incorporated herein by reference. Preferred emollients and moisturizers are tocopherol, tocopheryl acetate, aloe, vegetable oils, mineral oil, petrolatum, jojoba oil, and mixtures thereof. More preferred are encapsulated or spray/freeze dried emollients. The use of spray/freeze dried or encapsulated emollients keeps the emollients protected in the powder carrier until they are released through shearing (such as rubbing against undergarments or clothes) or through contact with skin moisture. Examples of preferred commercial spray/freeze dried aloe useful in the present invention are Terra-Dry™ Freeze Dried Aloe, Terra-Pure™ Freeze or Spray Dried Aloe, and Terra-Spray ™ Spray Dried Aloe, all from Terry Laboratories. When present, the emollients/moisturizers comprise from about 0.1% to about 50%, preferably from about 0.1% to about 25%, most preferably from about 0.1% to about 10%, by weight of the composition. SLIP COMPOUNDS The present compositions may optionally comprise slip compounds. The term "slip compounds", as used herein, refers to compounds which have unique structures which provide enhanced slip/lubrication characteristics of powders and/or reduced skin to skin friction between intertriginous skin sites. Slip compounds of the present invention include polyethylene; nylon; polytetra- fluoroethylene; silica which is in the form of microspheres, ellipsoids, barrel-shapes, and the like; mica, silicone (e.g. dimethicone) and metallic stearates (e.g. zinc stearate); and mixtures thereof. Preferred slip compounds are silicas which are in the form of microspheres, ellipsoids, barrel-shapes, and the like. Silica ellipsoids useful in the present invention are available from DuPont as ZELEC® Sil. Silica microspheres are available from KOBO as MSS-500, MSS 500/3, MSS-500/H, MSS-500/3H, MSS-500/N, and MSS-500/3N. Additionally, it is preferred that some of the silica of the present invention be fumed silica for increased flowability of the powder in addition to enhancing the slip characteristics. Fumed silica is available from Cabot Corporation (Cab-O-Sil®) and from Degussa (Aerosil®). When present in the compositions of the invention, the slip compounds comprise from about 0.1% to about 35% , preferably from about 1% to about 10%, by weight of the composition. BINDERS The present invention may optionally also include dry or wet binders to help promote adhesion of the powder and active ingredients to the skin. Binders useful in the present invention are found in the Cosmetic Bench Reference. 1994 Edition, pages 13-14, which is incorporated herein by reference. Preferred binders are calcium stearate, zinc stearate, isopropyl myristate, magnesium myristate, silicone, and mixtures thereof. More preferred are zinc stearate, dimethicone, and mixtures thereof. When included in the composition, the binders are at a level of from about 0.1% to about 25%, preferably from about 1% to about 15%, by weight of the composition. ANTI-PRURΓΓIC AGENTS Anti-pruritic agents such as those known in the art may be included in the compositions of the present invention. Examples of anti-pruritic agents useful in the present invention are Magnesium-L-Lactate, hydrocortisone, hydrocortisone acetate, and colloidal oatmeal. A description of anti-pruritic agents are found in the Handbook of Non Prescription Drugs. 10th Edition, p. 529, 1993; which is incorporated herein by reference. When included in the composition, anti-pruritic agents may be present from about 0.1% to about 40%, by weight of the composition.. COLORANTS Colorants and dyes can be optionally added to the odor absorbing compositions for visual appeal and performance impression. Colorants suitable for use in the present invention are found in the Cosmetic Bench Reference. 1994 Edition, pages 21-22, which is incorporated herein by reference PROCESS OF MAKING COMPOSITIONS The compositions of the present invention are prepared by the following steps: creating a mixture by mixing cyclodextrin, highly effective moisture absorbers (if present), and optional ingredients in a powder carrier via a commercially available mixer such as a vee-blender, double cone blender, or ribbon blender until the mixture is uniform; and creating a reduced size mixture using a commercially available size reduction technique such as hammer milling, impact milling, ball milling, or fluid energy milling until the desired particle size distribution is achieved. Since the compositions of the present invention are to be applied directly to the skin or hair, various applicators are useful for delivering the compositions to the occluded skin sites for maximum odor control. For example, the compositions are preferably deposited in a bottle, a canister, a spray dispenser, a manually activated spray dispenser, or on a wipe structure which later is contacted with the skin to transfer the composition to the skin. Bottles and canisters known in the art are suitable for use in delivering the compositions of the present invention. Bottles and canisters preferably comprise lids with small apertures for convenient dispensing of the composition. The composition of the present invention can also be delivered as a suspended solution via a spray dispenser or a bottle, such that when applied or sprayed onto the skin, the solvent would immediately dry/volatilize off to leave a powder film. Examples of such suspension forms are aerosols, liquid powder suspensions, or silicone suspensions. When present in an aerosol composition, the powders of the present invention will usually be present in the range of from about 0.1% to about 15%, by weight of the composition. The incorporation of a powder into an aerosol is more fully explained in U.S. Patent No. 4,078,051, to Pomot et al., issued March 7, 1978; which is incorporated herein by reference in its entirety. This method is not preferred however for use on sensitive areas of the body such as the panty-area or other occluded skin areas since skin irritations may result from propellants commonly used in aerosol containers. Preferred is a manually activated spray dispenser which delivers the composition as a powder without the use of propellants, and without the composition being in a solution form. Spray dispensers useful in the present invention are described more fully in U.S. Patent No. 2,450,205, to Rose, issued September 28, 1948; and U.S. Patent No. 2,840,277, to Bach, issued June 24, 1958, both of which are incorporated herein by reference in their entireties. Any wipe structures and/or methods of making the wipe structures commonly known in the art may be used in the present invention. The wipe comprises a flexible dispensing means. The term "flexible dispensing means", as used herein, includes papers, cloths, non- wovens, films, foams, sponges, rollers, pads, tissues, cotton balls, and the like. Preferred wipe substrates comprise a porous material, such as the non-woven substrates, foams, or sponges, which are capable of holding the composition within the pores of the substrates. Examples of cellulosic non-wovens particularly useful and economic in the present invention is described in U.S. Patent Number 4,191,609, Trokhan, issued March 4, 1980 which is incorporated herein by reference in its entirety. Techniques for combining the wipe substrates with the composition of the present invention are well known in the art. Examples of common methods of combining the composition to the wipe substrate may involve coating, immersing, dipping, sprinkling, or spraying, the wipe substrate with the composition of the present invention. The composition of the present invention is added to the wipe substrate at a level sufficient to provide the desired odor control and/or other desired skin benefits of the present invention. USE OF THE POWDER COMPOSITION The present invention also encompasses the use of the compositions described herein in reducing body odor and excess moisture on a human comprising the application of the compositions described herein to occluded skin. The present invention also encompasses the use of the compositions described herein in reducing vaginal odor on a human comprising applying the compositions described herein onto a pelvic region, external vagina, and/or panty-area. However, the compositions of the present invention should not be inserted into the vagina, nor applied onto the vulva. An "effective amount" of the compositions of the present invention, as used herein, means an amount sufficient to absorb body odor and/or excess moisture to the point that body odor is not discernible by the human sense of smell and excess moisture is not present. The compositions of the present invention are topically applied directly to the skin or hair. The compositions can be delivered by placing the composition into a dispensing means and applying an effective amount via spraying, sprinkling, shaking, or rubbing the composition onto the desired skin surface. Preferably the dispensing means is a canister, a spray bottle, or a pre-formed wipe which comprises a flexible dispensing means. Alternatively, the user may deposit the composition of the present invention onto a wipe comprising a flexible dispensing means of his or her own choosing. To do this, the user simply chooses a flexible dispensing means such as a washcloth or puff; transfers the composition of the present invention from a bottle or other suitable container over the chosen flexible dispensing means, and applies the composition to the desired area of the body. The user may also use his her hand to apply the compositions of the present invention. The user may use as much or as little of the composition of the present invention as he/she desires, depending upon their intended use and degree of odor and moisture control necessary. The following non-limiting examples illustrate the formulations and methods of use of the present invention. EXAMPLE I EXAMPLE II Ingredient %W/W Ingredient %W/W Corn Starch (Topical Starch) 64.80 Corn Starch (Topical Starch) 52.20 Silica (Microspheres) 2.00 Talc 10.00 Fumed Silica 2.00 Silica (Microspheres) 3.00 Zinc Phenolsulfonate 3.00 Fumed Silica 1.00 Triclosan .20 Zinc Phenolsulfonate 3.00 Cyclodextrin 3.00 Triclosan 0.30 Aloe Vera, Freeze/Spray Dried 1.00 Cyclodextrin 13.00 Nylon- 12 5.00 Aloe Vera, Freeze/Spray Dried 0.50 Zinc Stearate 7.00 Nylon- 12 5.00 Tocopheryl Acetate 2.00 Zinc Stearate 3.00 Microcapsules Dimethicone 10.00 Tocopheryl Acetate 2.00 Microcapsules Mineral Oil 2.00 Dimethicone 5.00 Total 100.00 Total 100.00 Examples I and II may also comprise a colorant and/or an anti-pruitic agent such as Magnesium-L-Lactate. EXAMPLE III EXAMPLE IV Ingredient %w/w Ingredient %W/W Rice Starch 54.50 Aluminum Starch Octenyl 30.80 Succinate (Dry Flo®Pure) Mica 2.00 Silica (Ellipsoids) 4.00 Silica (Ellipsoids) 2.00 Zinc Phenolsulfonate 7.00 Fumed Silica 1.00 Triclosan 0.60 Triclosan 0.50 Cyclodextrin 10.00 Aluminum Chlorohydrate 5.00 Aloe Vera Gel/Oil 1.00 Cyclodextrin 6.00 Zeolite 10.00 Aloe Vera, Freeze/Spray Dried 1.00 Talc 13.60 Polyethylene Powder 5.00 Polyethylene Powder 7.00 Zinc Stearate 5.00 Zinc Stearate 5.00 Tocopheryl Acetate Oil (Vit. E. 3.00 Mineral Oil 5.00 Acetate) Dimethicone 10.00 Dimethicone 6.00 Nylon N- 12 5.00 Total 100.00 Total 100.00 Example III may also comprise a zeolite. EXAMPLE V EXAMPLE VI Ingredient %W W Ingredient %W W Tapioca Starch 54.60 Corn Starch (Topical Starch) 29.25 Talc 4.90 Oat Flour/Colloidal Oatmeal 16.35 Silica (Microspheres) 2.50 Silica (Microspheres) 2.50 Fumed Silica 2.00 Silica (Ellipsoids) 1.50 Zinc Oxide 4.00 Kaolin 8.00 Triclosan 1.00 Zinc Oxide 2.00 Cyclodextrin 4.00 Triclosan 0.40 Aloe Vera Gel/Oil 2.00 Cyclodextrin 5.00 Nylon-12 10.00 Aloe Vera Gel/Oil 2.00 Zinc Stearate 6.00 Nylon-12 4.00 Isopropyl Myristate 4.00 Polyethylene Powder 4.00 Dimethicone 5.00 Zinc Stearate 10.00 Tocopheryl Acetate 5.00 Mircocapsules Dimethicone 10.00 Total 100.00 Total 100.00 Examples V and VI may also comprise sodium bicarbonate. EXAMPLE VII EXAMPLE Vm Ingredient %W W Ingredient %WAV Corn Starch (Topical Starch) 50.80 Corn Starch (Topical Starch) 26.70 Kaolin 14.50 Silica (Microspheres) 10.00 Silica (Microspheres) 2.50 Fumed Silica 5.00 Silica (Ellipsoids) 1.50 Zinc Phenolsulfonate 3.00 Fumed Silica 0.50 Triclosan 0.20 Zinc Phenolsulfonate 2.00 Cyclodextrin 3.00 Triclosan 0.20 Aloe Vera, Freeze/Spray Dried 0.10 Cyclodextrin 8.00 Magnesium Carbonate 8.00 Aloe Vera Gel/Oil 3.00 Nylon-12 5.00 Nylon-12 2.00 Calcium Silicate 20.00 Polyethylene Powder 5.00 Zinc Stearate 7.00 Tocopheryl Acetate 3.00 Tocopheryl Acetate 2.00 Microcapsules Mircocapsules Isopropyl Myristate 2.00 Dimethicone 10.00 Dimethicone 5.00 Total 100.00 Total 100.00 Example VII and VIII may also comprise an anti-pruritic agent such as Magnesium-L- Lactate. EXAMPLE IX EXAMPLE X Ingredient %W/W Ingredient %W/W Corn Starch (Topical Starch) 23.20 Rice Starch 23.40 Talc 10.00 Mica 2.00 Silica (Microspheres) 10.00 Silica (Ellipsoids) 14.50 Fumed Silica 5.00 Fumed Silica 5.00 Zinc Phenolsulfonate 3.00 Triclosan 0.10 Triclosan 0.30 Aluminum Chlorohydrate 5.00 Cyclodextrin 3.00 Cyclodextrin 6.00 Aloe Vera, Freeze/Spray Dried 0.50 Aloe Vera, Freeze/Spray Dried 1.00 Magnesium Carbonate 8.00 Calcium Carbonate 10.00 Nylon-12 5.00 Polyethylene Powder 3.00 Calcium Silicate 20.00 Calcium Silicate 10.00 Zinc Stearate 3.00 Zinc Stearate 7.00 Tocopheryl Acetate 2.00 Tocopheryl Acetate Oil (Vit. E 3.00 Microcapsules Acetate) Mineral Oil 2.00 Dimethicone 10.00 Dimethicone 5.00 Total 100.00 Total 100.00 Examples LX and X may also comprise a zeolite and/or a colorant. EXAMPLE XI EXAMPLE XII Ingredient %W/W Ingredient %W/W Aluminum Starch Octenyl 17.40 Tapioca Starch 13.10 Succinate Silica (Ellipsoids) 8.00 Talc 4.90 Fumed Silica 8.00 Silica (Microspheres) 20.00 Zinc Phenolsulfonate 7.00 Fumed Silica 2.00 Triclosan 0.60 Zinc Oxide 4.00 Cyclodextrin 10.00 Triclosan 1.00 Aloe Vera Gel/Oil 1.00 Cyclodextrin 4.00 Magnesium Carbonate 7.00 Aloe Vera Gel/Oil 2.00 Calcium Carbonate 3.00 Magnesium Carbonate 5.00 Polyethylene Powder 7.00 Calcium Carbonate 4.00 Calcium Silicate 15.00 Nylon-12 10.00 Zinc Stearate 5.00 Calcium Silicate 15.00 Mineral Oil 5.00 Zinc Stearate 6.00 Dimethicone 6.00 Isopropyl Myristate 4.00 Dimethicone 5.00 Total 100.00 Total 100.00 EXAMPLE XIII EXAMPLE XIV Ingredient %W/W Ingredient %w/w Corn Starch (Topical Starch) 10.25 Corn Starch (Topical Starch) 8.80 Oat Flour/Colloidal Oatmeal 8.35 Kaolin 4.00 Silica (Microspheres) 5.00 Silica (Microspheres) 5.00 Silica (Ellipsoids) 10.00 Silica (Ellipsoids) 5.00 Fumed Silica 5.00 Fumed Silica 5.00 Zinc Oxide 2.00 Zinc Phenolsulfonate 2.00 Triclosan 0.40 Triclosan 0.20 Cyclodextrin 5.00 Cyclodextrin 8.00 Aloe Vera Gel/Oil 2.00 Aloe Vera Gel/Oil 3.00 Magnesium Carbonate 4.00 Magnesium Carbonate 10.00 Calcium Carbonate 5.00 Nylon-12 2.00 Nylon-12 4.00 Polyethylene Powder 5.00 Polyethylene Powder 4.00 Calcium Silicate 25.00 Calcium Silicate 10.00 Zinc Stearate 7.00 Zinc Stearate 10.00 Tocopheryl Acetate 3.00 Microcapsules Tocopheryl Acetate 5.00 Isopropyl Myristate 2.00 Microcapsules Dimethicone 10.00 Dimethicone 5.00 Total 100.00 Total 100.00 Examples XIII and XTV may also comprise sodium bicarbonate. Prepare the above Examples by the following steps: create a mixture by mixing cyclodextrin, highly effective moisture absorbers, optional dry ingredients, and a powder carrier in a commercially available mixer such as a vee-blender, double cone blender, or ribbon blender until the mixture is uniform; reduce the particle size of the mixture using a grinding/pulverizing technique such as hammer milling, impact milling, ball milling, or fluid energy milling; and create a second mixture by adding any liquid phase emollients, moisturizers, and or skin protectants to the mixture, preferably using spray atomization while mixing for a more even dispersion. The second mixture can then undergo a second pulverizing grinding step, and if desired, an air classifying operation. Preparation for Application to Skin: The compositions of the present invention, such as those formed from the examples may be loaded onto a wipe or deposited into a spray device or canister. The compositions may be applied directly onto the skin or into/onto a flexible dispensing means of the user's choosing for convenient application to the skin. To prepare wipes: Coat, sprinkle, or spray the composition onto a dry flexible dispensing means until desired coating or thickness of the composition on the flexible dispensing means is achieved. To prepare sprav: Deposit the composition into the selected spray package. Close the package for storage until consumer use. To prepare a pressurized aerosol spray, transfer the composition into a suitable container. Pressurize and seal the container after injection of propellant materials. Example XV A woman with stress urinary incontinence finds that the wetness associated with this condition causes vaginal odor and discomfort. She wishes to reduce both the excess moisture and the vaginal odor. After urinating, the woman wipes her external vagina and pelvic region with a wipe containing the composition in Example VI. The woman notices less odor after using the wipes. Alternatively, the woman uses the composition in Example XIV and notices less odor and less moisture after using the wipes. Example XVI A large-breasted woman finds that when she exercises, she tends to experience sweating and skin chafing under the breasts. Before and after exercising, she applies the composition from Example III via a manual spray bottle. She sprays the composition under her breasts and the woman notices less odor and feels more comfortable after using the powder spray. Alternatively, the woman uses the composition in Example XrV and notices less odor and less moisture after using the wipes. Example XVII A man has severe allergies to cosmetic deodorants and antiperspirants and avoids using such products. This results in uncontrolled and embarrassing body odor due to excess moisture build up. His doctor suggests applying the mild odor and moisture absorbing composition of Example I or VIII. The man applies the composition to his entire body via a spray each morning after showering, and suffers no allergic reaction. The man notices less odor when using the composition of either Example I or VIII, and notices a marked reduction of moisture with the composition of Example VIII. The man keeps a pouch of wipes at work, which also contain the composition of Example VIII, for convenient and discrete reapplication as needed, particularly on hot and sweaty days. Example XVHI An obese woman has several large abdominal skin folds wherein excess moisture often accumulates causing body odor. She wishes to reduce her body odor as well as the excess moisture. The woman applies the composition of Example IV by sprinkling the composition from a bottle into the palm of her hand and rubbing the composition into the intertriginous regions between her skin folds as well as other occluded skin sites. The woman notices less odor. Alternatively, the woman uses the composition in Example XI and notices less odor and less moisture after using the wipes.

Claims: WHAT IS CLAIMED IS: 1. An odor absorbing composition comprising: a. 0.1% to 25%, by weight of the composition, of uncomplexed cyclodextrin; and b. a powder carrier; and wherein said composition is safe for use on skin. 2. The composition according to Claim 1 further comprising slip compounds. 3. An odor and moisture absorbing composition comprising: a. 0.1 % to 25 %, by weight of the composition, of uncomplexed cyclodextrin; b. a powder carrier; and c. 5% to 60%, by weight of the composition, of a highly effective moisture absorber; and wherein said composition is safe for use on skin. 4. The composition of Claim 3 wherein the highly effective moisture absorbers are selected from the group consisting of silicates, silicas, and carbonates. 5. The composition of Claim 4 wherein the highly effective moisture absorbers are selected from the group consisting of calcium silicate, amorphous silicas, calcium carbonate, magnesium carbonate, and zinc carbonate. 6. The composition according to any one of the preceding Claims wherein the cyclodextrin is selected from the group consisting of beta-cyclodextrins, derivatives of beta- cyclodextrins, alpha-cyclodextrins, derivatives of alpha-cyclodextrins, gamma-cyclodextrins, derivatives of gamma-cyclodextrins, and mixtures thereof. 7. The composition according to any one of the preceding Claims wherein particle sizes are from 1 micron to 100 microns, preferably from 1 to 60 microns, most preferably from 1 to 20 microns. 8. The composition according to any one of the preceding Claims wherein particle sizes of the cyclodextrin are from 1 to 12 microns, and most preferably from 1 to 5 microns. 9. The composition according to any one of the preceding Claims further comprising adjunct odor controlling agents selected from the group consisting of zeolites, activated charcoal, sodium bicarbonate, antimicrobial agents, and antiperspirants. 10. The composition any one of the preceding Claims further comprising skin aids selected from the group consisting of skin protectants, emollients, and moisturizers. 11. A pre-formed wipe composition wherein the composition according to any one of the preceding Claims is deposited on a wipe which comprises a flexible dispensing means. 12. The composition according to any one of the preceding Claims delivered as a powder by a manually activated spray dispenser. 13. The use, in reducing body and/or vaginal odor, of an odor absorbing composition comprising: a. 0.1% to 25%, by weight of the composition, of uncomplexed cyclodextrin; and b. a powder carrier; wherein the composition is applied to occluded skin, a pelvic region, an external vagina, and or a panty-area. 14. The use, in reducing body and or vaginal odor and excess moisture, of an odor and moisture absorbing composition comprising: a. 0.1% to 25%, by weight of the composition, of uncomplexed cyclodextrin; b. 5% to 60%, by weight of the composition, of a highly effective moisture absorber; and c. a powder carrier; wherein the composition is applied to occluded skin, a pelvic region, an external vagina, and or a panty-area.

Inventors: LAFLEUR PATRICIA ALISON, PETERSON LIEZL GONZALES, LAFLEUR, PATRICIA, ALISON, PETERSON, LIEZL, GONZALES
Applicants: PROCTER & GAMBLE, THE PROCTER & GAMBLE COMPANY
Application year: 1997
Main classification: A61K7
IPC codes: A61K8, A61Q15